MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

112.65 +3.09 (+2.82%)
Official Closing Price Updated: 7:00 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,560,883
Open 109.42
Bid (Size) 112.00 (400)
Ask (Size) 112.50 (100)
Prev. Close 109.56
Today's Range 108.94 - 112.74
52wk Range 105.27 - 139.15
Shares Outstanding 1,750,942,289
Dividend Yield 2.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
2 Profitable Stocks on Our Watchlist and 1 We Avoid
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory

Performance

YTD
-9.3%
-9.3%
1 Month
+1.6%
+1.6%
3 Month
-7.7%
-7.7%
6 Month
-14.8%
-14.8%
1 Year
-18.0%
-18.0%

More News

Read More
News headline image
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
2 Reasons to Like ABT and 1 to Stay Skeptical
Via StockStory
Topics Stocks Supply Chain
News headline image
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗
Via The Motley Fool
Topics Cannabis Initial Public Offering
News headline image
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
Via MarketMinute
News headline image
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
3 Large-Cap Stocks with Solid Fundamentals
Via StockStory
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
Via MarketMinute
Topics Earnings
News headline image
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down
Via StockStory
News headline image
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky
Via StockStory
News headline image
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever ↗
Via The Motley Fool
News headline image
1 Reason I'm Never Selling AbbVie Stock ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Via Finterra
Topics Artificial Intelligence Economy Product Recall
News headline image
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal ↗
Via MarketBeat
News headline image
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
Via Finterra
Topics Product Recall World Trade
News headline image
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
From Brodsky & Smith LLC
Via GlobeNewswire

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 112.65
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 03/09/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 197.24B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 197B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story